(Q73156189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Karl-Hermann Meyer zum Büschenfelde

6

object named as

K H Meyer zum Büschenfelde

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

S Kanzler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Weidemann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Gerken

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H F Löhr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P R Galle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A W Lohse

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

635-640

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

Meeting report: International Autoimmune Hepatitis Group

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Classification of auto-immune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Autoimmunity and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

The natural course and heterogeneity of autoimmune-type chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

1 reference

7 January 2021

Autoimmune hepatitis: classification, heterogeneity, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Serological definition of new subgroup of patients with autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Subdivisions of idiopathic autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

How many types of autoimmune hepatitis are there?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Seroimmunologic classification of chronic hepatitis in 57 children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Type II autoimmune hepatitis. What is the role of the hepatitis C virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Therapeutic concepts for the management of idiopathic autoimmune chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Autoimmune hepatitis. Evolving concepts and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Autoimmune hepatitis in childhood: a 20-year experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980342-0

7 January 2021

10.1016/S0168-8278(99)80342-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551386%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference